Explore

Trendline Trendline
Challenges in Drug Discovery Highlight Need for Human-Centric Preclinical Models

Challenges in Drug Discovery Highlight Need for Human-Centric Preclinical Models

Challenges in Drug Discovery Highlight Need for Human-Centric Preclinical Models
Trendline Trendline
AbelZeta's C-CAR168 Receives EMA PRIME Designation for Lupus Treatment

AbelZeta's C-CAR168 Receives EMA PRIME Designation for Lupus Treatment

AbelZeta's C-CAR168 Receives EMA PRIME Designation for Lupus Treatment
Trendline Trendline
Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors

Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors

Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors
Trendline Trendline
Verismo Therapeutics Expands Solid Tumor Treatment Pipeline with New CLDN6 Binder

Verismo Therapeutics Expands Solid Tumor Treatment Pipeline with New CLDN6 Binder

Verismo Therapeutics Expands Solid Tumor Treatment Pipeline with New CLDN6 Binder
Trendline Trendline
Novartis Reports Growth Despite Entresto Sales Decline Due to Generic Competition

Novartis Reports Growth Despite Entresto Sales Decline Due to Generic Competition

Novartis Reports Growth Despite Entresto Sales Decline Due to Generic Competition
Trendline Trendline
Innate Pharma Completes Enrollment in Phase 1 Study of Novel Cancer Treatment

Innate Pharma Completes Enrollment in Phase 1 Study of Novel Cancer Treatment

Innate Pharma Completes Enrollment in Phase 1 Study of Novel Cancer Treatment
Trendline Trendline
Ashlins Pharmaceuticals Secures Exclusive License with Lee's Pharm for Interferon Alpha-2b Development

Ashlins Pharmaceuticals Secures Exclusive License with Lee's Pharm for Interferon Alpha-2b Development

Ashlins Pharmaceuticals Secures Exclusive License with Lee's Pharm for Interferon Alpha-2b Development
Trendline Trendline
Atossa Therapeutics Presents (Z)-Endoxifen Data for McCune-Albright Syndrome at AACR Conference

Atossa Therapeutics Presents (Z)-Endoxifen Data for McCune-Albright Syndrome at AACR Conference

Atossa Therapeutics Presents (Z)-Endoxifen Data for McCune-Albright Syndrome at AACR Conference
Trendline Trendline
Xencor's XmAb819 Phase 1 Study Results to be Presented at ESMO 2026, Highlighting Potential in Renal Cell Carcinoma

Xencor's XmAb819 Phase 1 Study Results to be Presented at ESMO 2026, Highlighting Potential in Renal Cell Carcinoma

Xencor's XmAb819 Phase 1 Study Results to be Presented at ESMO 2026, Highlighting Potential in Renal Cell Carcinoma
Trendline Trendline
Bristol Myers Squibb Partners with NVIDIA to Build Advanced AI Supercomputer for Drug Discovery

Bristol Myers Squibb Partners with NVIDIA to Build Advanced AI Supercomputer for Drug Discovery

Bristol Myers Squibb Partners with NVIDIA to Build Advanced AI Supercomputer for Drug Discovery
Trendline Trendline
Incyte to Present Data on Cancer Treatments at ESMO Congress 2026

Incyte to Present Data on Cancer Treatments at ESMO Congress 2026

Incyte to Present Data on Cancer Treatments at ESMO Congress 2026
Trendline Trendline
IntraBio Publishes Research on Levacetylleucine's Impact on Lysosomal Function

IntraBio Publishes Research on Levacetylleucine's Impact on Lysosomal Function

IntraBio Publishes Research on Levacetylleucine's Impact on Lysosomal Function